These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H. FASEB J; 2007 Jun 30; 21(8):1707-13. PubMed ID: 17327360 [Abstract] [Full Text] [Related]
13. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, Ishii I. Hum Mol Genet; 2008 Jul 01; 17(13):1994-2005. PubMed ID: 18364386 [Abstract] [Full Text] [Related]
14. Effect of nephrotic syndrome on homocysteine metabolism. Aminzadeh MA, Gollapudi P, Vaziri ND. Nephrol Dial Transplant; 2011 Apr 01; 26(4):1244-7. PubMed ID: 20826746 [Abstract] [Full Text] [Related]
15. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. Jakubowski H. J Physiol Pharmacol; 2008 Dec 01; 59 Suppl 9():155-67. PubMed ID: 19261978 [Abstract] [Full Text] [Related]
16. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients. Heil SG, Riksen NP, Boers GH, Smulders Y, Blom HJ. Mol Genet Metab; 2007 May 01; 91(1):55-60. PubMed ID: 17336565 [Abstract] [Full Text] [Related]